Universal Health International Group Holding (HKSE:02211) Total Equity: HK$381.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02211 Universal Health International Group Holding Ltd HKSE:02211
37 GF Score
Price HK$0.66
GF Value HK$0.29
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Universal Health International Group Holding Total Equity?

Universal Health International Group Holding HKSE:02211 -7.75% 37 Total Equity is HK$381.0 Mil as of Dec. 2025. GuruFocus rates HKSE:02211 with a GF Score™ of 37/100 and a GF Value™ of HK$0.29 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Universal Health International Group Holding's total equity for the quarter that ended in Dec. 2025 was HK$381.0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Universal Health International Group Holding Total Equity Historical Data

* Premium members only.

The historical data trend for Universal Health International Group Holding's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Health International Group Holding Total Equity Chart

Universal Health International Group Holding Annual Data
Trend Dec14 Dec15 Dec16 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 692.18 479.08 339.53 379.18 347.91

Universal Health International Group Holding Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 354.38 379.18 362.29 347.91 380.98
HKSE:02211
37GF Score
Universal Health International Group Holding Ltd HKSE:02211
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Universal Health International Group Holding Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Universal Health International Group Holding's Total Equity for the fiscal year that ended in Jun. 2025 is calculated as

Total Equity=Total Assets(Q: Jun. 2025 )-Total Liabilities(Q: Jun. 2025 )
=490.36125183169-142.45030353779
=347.9

Universal Health International Group Holding's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=539.49145253035-158.51356739624
=381.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of HK$381.0 Mil mean?
Universal Health International Group Holding (HKSE:02211) has a Total Equity of HK$381.0 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Universal Health International Group Holding and its competitors.
Is Universal Health International Group Holding's Total Equity too high?
Universal Health International Group Holding's current Total Equity is HK$381.0 Mil. Overall, Universal Health International Group Holding has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Universal Health International Group Holding's Total Equity compare to competitors?
Universal Health International Group Holding's Total Equity of HK$381.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Healthcare Providers & Services company?
A good Total Equity depends on the Healthcare Providers & Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Universal Health International Group Holding and its competitors. Universal Health International Group Holding's current Total Equity is HK$381.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Health International Group Holding stock overvalued right now?
Based on GuruFocus' analysis, Universal Health International Group Holding (HKSE:02211) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.29, compared to a current price of HK$0.66 — trading 125.9% above its estimated fair value. The current Total Equity is HK$381.0 Mil. Universal Health International Group Holding's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Universal Health International Group Holding (HKSE:02211), the current Total Equity is HK$381.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Universal Health International Group Holding (HKSE:02211) Overvalued in 2026?

Based on GuruFocus' analysis, Universal Health International Group Holding stock appears to be overvalued. The current stock price of HK$0.66 is trading 125.9% above its estimated GF Value™ of HK$0.29. GuruFocus considers Universal Health International Group Holding to be Significantly Overvalued.

Key valuation signals for HKSE:02211:

  • Total Equity: HK$381.0 Mil
  • GF Value™: HK$0.29 vs. price of HK$0.66 (125.9% above fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the HKSE:02211 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universal Health International Group Holding Business Description

Address No. 14-1, Bei Yi Zhong Road, Tiexi District, Liaoning Province, Shenyang, CHN
Universal Health International Group Holding Ltd distributes and retails pharmaceutical products in Northeast China. The company operates its business through two segments: pharmaceutical retail and Distribution, (including import and export trade) include prescribed drugs, non-prescribed drugs (Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs), traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, blood products, disinfection products, medical equipment, etc. and majority of revnue comes from Distribution segment.
37GF Score

Get the complete analysis for HKSE:02211

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.66
Price
HK$0.29
GF Value